Marker Therapeutics, Inc. (MRKR)

1.48 +0.01 (+0.68%) USD  |  NASDAQ  |  Dec 31, 16:00
1.48 0.00 (0.00%) After-Hours: 20:00
More

Marker Therapeutics Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade